ACI
CPXX

Alpha Cubed Investments’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Alpha Cubed Investments’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-32,092
Closed -$63K – 184
2014
Q4 		$63K Hold
32,092
– – 0.02% 137
2014
Q3 		$81K Hold
32,092
– – 0.04% 144
2014
Q2 		$95K Buy
+32,092
New +$88.4K 0.04% 166

Other funds holding CPXX

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alpha Cubed Investments's CPXX Position: Q1 2015 in Review

Alpha Cubed Investments sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q1 2015, closing a stake of 32,092 shares — an estimated $63K sold.

Alpha Cubed Investments first reported a position in CPXX in Q2 2014 and held it in 3 quarters. The position peaked at $95K in Q2 2014. 15 funds tracked by Wall St. Rank hold CPXX as of Q1 2015.

  • Alpha Cubed Investments reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q1 2015 after selling out during the quarter.
  • Alpha Cubed Investments sold 32,092 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q1 2015, an estimated $63K.
  • Alpha Cubed Investments first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2014 and held it in 3 quarters.
  • Alpha Cubed Investments's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $95K in Q2 2014.
  • 15 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q1 2015.

Based on Alpha Cubed Investments's 13F filing for Q1 2015, filed 13 May 2015.